Results for technologies (2)
Advanced filter
Sensitizing Non-Small Cell Lung Cancer (NSCLC) to Immunotherapy (No. T4-2082)
non-small cell lung cancer (NSCLC) has a poor prognosis and low survival rates. Recently developed immunotherapy has revolutionized the therapy for NSCLC, significantly prolonging the overall survival of advanced‑stage patients.
NSCLC comprises approximately 85-90% of all known ...
Read more
7108
A method to identify actively degraded proteins (No. T4-1832)
This technology provides a method to identify the full landscape of proteins that are actively being degraded by the proteasome, offering a way to identify novel targets in various biological conditions and contexts.
The cell's proteome (protein profile) is constantly changing du...
Read more
6030